More than 31,700 healthcare professionals from 153 countries gathered in Barcelona for ESC Congress. The event featured 20 Late Breaking Clinical Trials, 12 Late Breaking Registry Results and 12 Clinical Trial Updates, four new ESC Clinical Practice Guidelines and 4 515 abstracts. ESC Congress is the summit of cardiovascular medicine. Therefore it is seen by healthcare professionals as the place to be for the latest developments in cardiology.
More than 31,700 healthcare professionals from 153 countries gathered in Barcelona for ESC Congress. The event featured 20 Late Breaking Clinical Trials, 12 Late Breaking Registry Results and 12 Clinical Trial Updates, four new ESC Clinical Practice Guidelines and 4 515 abstracts. ESC Congress is the summit of cardiovascular medicine. Therefore it is seen by healthcare professionals as the place to be for the latest developments in cardiology.
interviews
The treatments that may change the heart failure management
TAVI is noninferior to surgery in medium risk patients
Aggiornate le raccomandazioni per l'impiego della TAVI
The treatment effect of renal denervation has been demonstrated
REVEAL trial: clinical effects of anacetrapib in established VD
Benefits and risks of taking Aspirin lifelong
Clinical efficacy and safety of achieving very low LDL levels
Empaglifozin and Liraglutide for the CVD in type 2 diabetes
Linee guida ESC: trattamento TAVI anche per il rischio intermedio
Prasugrel vs Clopidogrel in over 75 after angioplasty
Prasugrel vs Clopidogrel negli over 75 dopo angioplastica
Study reveals: LDL lowering depends on how it is lowered
Is Ticagrelor really superior to Clopidogrel?
The REVEAL trial design
